Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital

Oslo University Hospital2,519 enrolled

Overview

Covid-19 is a recently emerging infectious disease with a very large impact on health care world-wide. The disease is still poorly described. It is an urgent need for better clinical characteristics. A prospective, quality register is therefore established for increasing the knowledge about the disease, the covid patients and the prognosis.

All patient hospitalized at Oslo University Hospital, Ullevål, is prospectively registered in the approved quality register. Background, clinical and paraclinical data is harvested and registered, as well as treatment and mortality.

Study Type

OBSERVATIONAL

Enrollment

2,519

Conditions

COVID-19

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed covid-19 * hospitalized Exclusion Criteria: * None

Locations (1)

Oslo University Hospital

Oslo, Norway

Outcomes

Primary Outcomes

Mortality

Mortality in hospitalized covid patients

Time frame: 3 month

Severe disease

Number of patients with severe disease

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.